Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCX140-B for albuminuria in type 2 diabetes
NCT01440257Phase 2Completed
- Sponsor
- Amgen
- Start
- Sep 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ilacirnon in diabetic nephropathy (DN), sponsored by Amgen. Started Sep 2011; status: completed.
02
Drugs
ilacirnon
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT01440257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01440257.